Company Description
Nevro Corp., a medical device company, engages in the provision of products for patients suffering from chronic pain in the United States and internationally.
The company provides HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic back and leg pain through paresthesia-free 10 kHz therapy, as well as offers Senza II and Senza Omnia SCS IPG systems.
It also offers Senza HFX iQ platform, that includes HFX iQ implantable pulse generator, HFX trial stimulator, and HFX iQ patient remote, as well as HFX App, a patient remote control and the wireless trialing system.
In addition, the company offers HFX AdaptivAI, a pain management platform that powers the HFX iQ SCS system as well as surpass surgical and percutaneous leads.
It sells its products through its direct sales force, and a network of sales agents and independent distributors.
The company was incorporated in 2006 and is c in Redwood City, California.
| Country | United States |
| Founded | 2006 |
| IPO Date | Nov 6, 2014 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 1,215 |
| CEO | Kevin Thornal |
Contact Details
Address: 1800 Bridge Parkway Redwood City, California 94065 United States | |
| Phone | 650 251 0005 |
| Website | nevro.com |
Stock Details
| Ticker Symbol | NVRO |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001444380 |
| CUSIP Number | 64157F103 |
| ISIN Number | US64157F1030 |
| Employer ID | 56-2568057 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Kevin R. Thornal | President, Chief Executive Officer and Director |
| Roderick H. MacLeod | Senior Vice President and Chief Financial Officer |
| Kashif Rashid J.D. | Senior Vice President of Corporate Development and Chief Legal Officer |
| Greg Siller | Senior Vice President and Chief Commercial Officer |
| Christofer Christoforou | Senior Vice President and Chief Operating Officer |
| Angeline C. McCabe | Vice President of Investor Relations and Corporate Communications |
| Shana D. Ross M.B.A. | Senior Vice President and Chief Human Resources Officer |
| Dr. David Caraway M.D., Ph.D. | Senior Vice President and Chief Medical Officer |
| Peter A. Socarras | Vice President, General Counsel and Corporate Secretary |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 10, 2025 | SCHEDULE 13G | Filing |
| Mar 10, 2025 | DEFM14A | Filing |
| Mar 4, 2025 | 10-K | Annual Report |
| Mar 4, 2025 | 8-K | Current Report |
| Feb 21, 2025 | PREM14A | Filing |
| Feb 20, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Feb 14, 2025 | SCHEDULE 13G/A | Filing |
| Feb 14, 2025 | SCHEDULE 13G/A | Filing |
| Feb 6, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Feb 6, 2025 | 8-K | Current Report |